Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Similar Items

• Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
  by: Feldmann, M, et al.
  Published: (1997)
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
  by: Elliott, M, et al.
  Published: (1994)
• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
  by: Paleolog, E, et al.
  Published: (1996)
• Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
  by: Williams, R, et al.
  Published: (2000)
• What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
  by: Feldmann, M
  Published: (1996)